Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs

Author(s):  Monnot Chris L

Issue:  Mar/Apr 2004 - Overview of USP Chapter <797>
View All Articles in Issue

Page(s):  123-125

An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs Page 1
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs Page 2
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs Page 3

Download in electronic PDF format for $75

Abstract:  The author provides a means for estimating the relative amount of sodium chloride needed to ensure that parenteral, nasal, ophthalmic or oral inhalation dosage forms are iso-osmotic or isotonic with body fluids. He presents an Excel spreadsheet that allows rapid calculation of the sodium-chloride equivalents (or E values) and an indicator of the relative extent of ionization of the drug in solution (or i factor). After the user loads the spreadsheet into Excel and inputs the drug name, molecular weight, pH (if required), pKa and number of ions formed by the drug in solution, the spreadsheet automatically calculates the E value and i factor for the drug. The spreadsheet is divided into calculations for weak acids and weak bases, and the user must determine the classification of the drug, along with the number of ions formed by the drug in solution. The author then provides step-by-step instructions for preparing the spreadsheet and a table providing a list of common drugs, the spreadsheet-calculated E values and the reference reported E values.

Related Keywords: Isotonic solutions, formulation of, Nasal administration, compounding for, Ophthalmic administration, compounding for, Oral inhalation, compounding for, Parenteral administration, compounding for, Sodium-chloride equivalents, for drugs, estimation of

Related Categories: SUPPORT, TECHNOLOGY, QUALITY CONTROL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs
Monnot Chris L
Mar/Apr 2004
Pg. 123-125

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, LlambĂ­ Francesc
Jan/Feb 2014
Pg. 6-12

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
Nov/Dec 2015
Pg. 508

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
Nov/Dec 2023
Pg. 474-481

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
Jul/Aug 2020
Pg. 296-297

Return to Top